Mt. Chateau et al., Human monocytes possess a serine protease activity capable of degrading HIV-1 reverse transcriptase in vitro, BIOC BIOP R, 285(4), 2001, pp. 863-872
Citations number
31
Categorie Soggetti
Biochemistry & Biophysics
Journal title
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS
Human immunodeficiency virus type-1 (HIV-1) reverse transcriptase (RT) play
s a central role in the virus replication cycle. We found that HIV-1 RT was
rapidly degraded when incubated with cell extracts obtained from human per
ipheral blood cells. The proteolytic activity responsible for the in vitro
degradation of RT was present in monocytes and their precursors. Interestin
gly, this activity was downregulated upon cell activation or differentiatio
n along the macrophage pathway. The proteolytic process appears specific fo
r HIV-1 RT since other HIV-1 proteins were not degraded upon incubation in
the same extracts. Although the degradation of RT was unaffected by specifi
c proteasome inhibitors, it could be inhibited by PMSF and aprotinin, sugge
sting the involvement of a serine protease. Upon cell fractionation, this s
erine protease was found to be associated with the microsomal fraction and
displayed an apparent molecular weight of approximately 2000 kDa, as determ
ined by gel filtration. Our results suggest that a giant serine protease, d
ifferent from tripeptidyl peptidase II, is involved in the in vitro degrada
tion of HIV-1 RT. The possibility of an in vivo interaction between HIV-1 R
T and a cell-type-specific serine protease is discussed. (C) 2001 Academic
Press.